GlassScriptPhysician profile
Vikram Budhraja
NPI 1275776510
$4,630.49
in general payments reported to CMS, 2019-2025
6 companies · $3,295 in 2025
The $3,295 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2022: $98.73 · 2023: $1,085 · 2024: $33.89 · 2025: $3,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,206 · Honoraria: $1,000 · Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,206.00 |
| Honoraria | $1,000.00 |
| Food and Beverage | $208.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $3,206.00 | 2025 | Evis Exera II Small Intestinal Videoscope |
| Erbe USA INC | $1,000.00 | 2023 | |
| Abbvie INC. | $137.91 | 2022-2024 | Skyrizi |
| Boston Scientific Corporation | $117.51 | 2019 | |
| Phathom Pharmaceuticals, INC. | $89.15 | 2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $79.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Budhraja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.